FibroGen Stock Plummets 30% In 21 Sessions: Is It Time To Sell?
(VIANEWS) – FibroGen (NASDAQ: FGEN) shares have seen an extraordinary decline of 30.15% over the last 21 sessions, falling from EUR1.36 to EUR0.95, continuing their downward momentum from prior sessions. Even as NASDAQ rose 0.83% to EUR13,928.34 during this time, FibroGen’s performance remains weak with their last closing price being EUR0.93, representing an approximately 96%…